Literature DB >> 8933830

Endometrial carcinoma in women 65 years of age or older: a clinicopathologic study.

T Kaku1, M Matsumura, K Sakai, N Tsuruchi, T Kamura, N Tsukamoto, H Nakano.   

Abstract

The purpose of this study is to clarify the clinical and pathologic features of endometrial carcinomas in women 65 years of age or older in Japan where the incidence of endometrial carcinoma is still low. Between 1979 and 1990, 24 of 164 patients with endometrial carcinoma were 65 years old or over. In addition, 41 patients 50 years of age or younger were also analyzed, comparing clinicopathologic features with those of older age group. Seventeen of 24 (71%) showed deep myometrial invasion (more than a half of the myometrium). Endometrial carcinomas in older age groups have deeper myometrial invasion, and higher histologic grade than those of younger age groups. The adjacent endometrium is usually atrophic and the presence of hyperplasia and/or metaplasia was significantly less frequent in the older group as compared with that in the younger group. Nine of these 24 patients died of disease in a relatively short follow-up period. The prognosis for the older group (expected 5-year survival 69.2%) is significantly worse than for the younger group (expected 5-year survival 94.3%) (P = 0.006). Endometrial carcinomas in patients over 65 years of age are usually of high histologic grade, and have deep myometrial invasion and an unfavorable prognosis.

Entities:  

Mesh:

Year:  1996        PMID: 8933830

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  2 in total

1.  Endometrial Carcinoma in a Young Woman: "30 is Not Immune".

Authors:  Sunanda Bharatnur; Pralhad Kustagi; Damayanthi Krishnamohan
Journal:  J Obstet Gynaecol India       Date:  2011-10-29

2.  Total laparoscopic hysterectomy versus total abdominal hysterectomy: cohort review of patients with uterine neoplasia.

Authors:  Katherine A O'Hanlan; Gloria Shining Huang; Anne-Caroline Garnier; Suzanne L Dibble; Mirjam L Reuland; Lisbeth Lopez; Rebecca L Pinto
Journal:  JSLS       Date:  2005 Jul-Sep       Impact factor: 2.172

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.